Medical research

Scientists develop a new type of anti-cancer agent

Many cancer therapies, in addition to producing numerous side effects, fail to achieve complete tumor remission, partly due to the presence of cancer stem cells, which are difficult to eradicate. These cells can self-renew ...

Oncology & Cancer

Targeting annexin-A1 can halt cancer cell growth, study finds

A new study published in Oncogene highlights the effectiveness of MDX-124, the first therapeutic drug to target annexin-A1, a protein that is overexpressed in several cancer types and promotes tumor progression.

Oncology & Cancer

Cracking the code: How what you eat might affect your cancer risk

There is an unresolved debate about the extent to which the environment contributes to cancer risk. Although epidemiological studies suggest that environmental factors such as diet can certainly contribute, especially for ...

page 4 from 40